Softwr

Healthcare · head to head

Omada Health vs Therapixel

Omada Health logo

Omada Health

Healthcare

Behavioral health management platform

From
On request
Rated
-
Therapixel logo

Therapixel

Healthcare

French mammography AI with FDA clearances for 2D and tomosynthesis breast screening

From
On request
Rated
-

The short version

  • Each has a real cost: Omada Health no direct-pay pricing disclosed; programs only available through employer or health plan coverage; Therapixel european and American regulatory positions were established under different regimes, and under the EU Medical Device Regulation this class of diagnostic AI faces a higher classification and notified body scrutiny, so European buyers must verify the current MDR certificate and expiry rather than relying on a legacy CE reference.
  • They diverge on capability: Omada Health covers Chronic Disease Management, Therapixel covers MammoScreen 2D.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Omada Health and Therapixel actually diverge.

Attributes where Omada Health and Therapixel differ
AttributeOmada HealthTherapixel
PlatformsWeb, MobileWeb
Founded2011Unknown

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Omada Health

  • Chronic Disease Management
  • Behavioral Health
  • Coaching
  • Mobile App
  • Analytics
  • Incentives
  • Health Plans
  • EHR Systems

Only in Therapixel

  • MammoScreen 2D
  • MammoScreen DBT
  • One to ten suspicion score
  • Summary report
  • Workstation and PACS delivery
  • Reading workflow configurations

What people use each for

The jobs each tool is most often brought in to do.

Omada Health

  • Employer-sponsored diabetes prevention and weight health programmesnot Therapixel
  • Remote monitoring of hypertension and diabetes with connected devicesnot Therapixel
  • GLP-1 support programmes alongside medicationnot Therapixel
  • Musculoskeletal care delivered virtuallynot Therapixel

Therapixel

  • A European breast screening programme running mandatory double reading that wants to evaluate AI as a concurrent or second reader within what national guidance permitsnot Omada Health
  • An American breast centre that has moved to tomosynthesis and needs reading support on DBT specifically, which Therapixel holds a clearance fornot Omada Health
  • A screening service wanting a graded suspicion score rather than a binary flag so readers can calibrate their own thresholdnot Omada Health
  • A radiology group evaluating multiple mammography AI vendors head to head on their own historic case set before committingnot Omada Health

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Omada Health

  • No direct-pay pricing disclosed; programs only available through employer or health plan coverage
  • Eligibility varies by employer and health plan
  • Government payer programs (Medicare/Medicaid) have different device access rules
  • MSK program may require out-of-pocket costs depending on individual health plans

Therapixel

  • European and American regulatory positions were established under different regimes, and under the EU Medical Device Regulation this class of diagnostic AI faces a higher classification and notified body scrutiny, so European buyers must verify the current MDR certificate and expiry rather than relying on a legacy CE reference.
  • MammoScreen does mammography only, so a hospital wanting AI across head CT, chest and breast needs several vendors and several PACS integrations, or an orchestration layer bought from someone else.
  • Therapixel is a small French company competing against Hologic and iCAD, which have incumbency inside the mammography reading workstation, so integration into an American breast centre is more work than it is for the workstation vendor own AI.
  • Detection performance is sensitive to the mammography unit vendor and acquisition protocol, so published results do not transfer between estates and each site needs local validation it must fund itself.
  • Whether AI can substitute for one of two human readers is a national workforce and liability question, not a product capability, so the labour saving that justifies the purchase in one country is not permitted in another.

Pricing, plan by plan

Omada Health

On request

No published plan breakdown. See the Omada Health review.

Therapixel

On request
  • MammoScreen$undefined/year
    • Priced per examination or by annual screening volume
    • 2D and tomosynthesis licensed by the versions cleared for each
    • Cloud or on premises deployment quoted differently

Which should you pick?

Choose Omada Health if

  • You need chronic disease management.
  • You work on Web, Mobile.
  • You also want behavioral health.

Choose Therapixel if

  • You need mammoscreen 2d.
  • You also want mammoscreen dbt.

Questions people ask

Is Omada Health or Therapixel better?
Neither clearly leads. Omada Health starts at On request and Therapixel at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Omada Health or Therapixel?
Omada Health starts at On request and Therapixel at On request.
Does Omada Health or Therapixel run on more platforms?
Omada Health runs on Web, Mobile. Therapixel runs on Web.
What is Omada Health best used for?
Omada Health is most often used for employer-sponsored diabetes prevention and weight health programmes, remote monitoring of hypertension and diabetes with connected devices, glp-1 support programmes alongside medication, musculoskeletal care delivered virtually. Of those, employer-sponsored diabetes prevention and weight health programmes and remote monitoring of hypertension and diabetes with connected devices are not what Therapixel is typically brought in for.
What can Omada Health do that Therapixel cannot?
Omada Health covers Chronic Disease Management, Behavioral Health, Coaching, Mobile App. Therapixel covers MammoScreen 2D, MammoScreen DBT, One to ten suspicion score, Summary report.

Answered from the vendors’ own pages

Omada Health: How much does Omada Health cost?

Omada Health programs are offered at no cost to members when covered by an employer or health plan. Direct-pay pricing for uninsured individuals is not disclosed on the website.

Source
Therapixel: Is MammoScreen FDA cleared?

Yes. It holds 510(k) clearance K192854 for two dimensional mammography from July 2020, a November 2021 clearance for digital breast tomosynthesis, and two further clearances in October 2024 for later versions.

Omada Health: Is Omada Health free?

Omada's Prevention, Diabetes, and Hypertension programs are free when covered by your employer or health plan. The Joint and Muscle Health program is subject to deductibles, copays, and co-insurance as determined under your health plan.

Source
Therapixel: Is it CE marked?

Yes, but European buyers should ask specifically for the current certificate under the Medical Device Regulation and its expiry date, because this class of diagnostic AI moved to a higher classification under MDR.

Omada Health: Do I need to pay for the Omada welcome kit with smart devices?

The welcome kit containing smart devices is offered at no cost to covered members. Continuous glucose monitors for diabetes program participants are also provided at no additional charge, though Medicare and Medicaid are excluded.

Source
Therapixel: What does the one to ten score mean?

It is a graded suspicion score per finding and per study, designed to be integrated alongside a radiologist BI-RADS assessment rather than treated as a positive or negative result.

Therapixel: Does it cover anything besides mammography?

No. It is a mammography product only, including tomosynthesis. Other body regions need a different vendor.

Share

Related pages

Other head to heads